Understanding Key Drivers and Growth Opportunities in the Non-Alcoholic Steatohepatitis Biomarkers Market: Trends and Market Size Insights
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Industry-Specific Factors Are Fueling the Growth of theNon-Alcoholic Steatohepatitis Biomarkers Market?
The escalating occurrence of liver cancer is anticipated to spur the expansion of the non-alcoholic steatohepatitis biomarkers market in the future. Liver cancer entails the formation of malignant tumors within the liver. This cancer can either originate within the liver (primary liver cancer) or metastasize from other body parts to the liver (secondary or metastatic liver cancer). Non-alcoholic steatohepatitis (NASH) biomarkers play a crucial role in liver cancer by allowing early detection, monitoring disease progression, assessing treatment response, and providing prognostic information. They also help to lessen the requirement for invasive procedures. For example, the World Cancer Research Fund, a non-profit organization based in the UK, reported approximately 866,136 new liver cancer cases globally in 2022, making liver cancer the 6th most common type of cancer worldwide. As such, the increasing incidence of liver cancer is stimulating the non-alcoholic steatohepatitis biomarkers market’s rise.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9002&type=smp
#What is the Growth Potential of the Non-Alcoholic Steatohepatitis Biomarkers Market, and How Will It Perform by 2034?
There has been significant expansion in the non-alcoholic steatohepatitis biomarkers market size over the past few years. It is projected to surge from $1.36 billion in 2024 to $1.7 billion in 2025, showing a compound annual growth rate (CAGR) of 24.8%. Factors like the prevalence of diabetes and metabolic syndrome, the increase in awareness and screening programs, the limitations of liver biopsy, regulatory support, the trend towards personalized medicine and NASH clinical trials have all contributed to the historical growth.
Anticipated to see immense expansion in the coming years, the non-alcoholic steatohepatitis biomarkers market’s size is predicted to reach $3.86 billion in 2029, experiencing a compound annual growth rate (CAGR) of 22.8%. Factors driving growth during the forecast period include the development of new therapies, advances in precision medicine, patient advocacy efforts, the merging of multi-omics data, and increased patient involvement. Key trends during this period include the use of telemedicine and remote monitoring systems, the development of novel diagnostic platforms, global cooperation in research, advancements in biomarker discovery technology, the incorporation of artificial intelligence (AI), and the addition of imaging biomarkers.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9002
What Key Market Trends and Innovations Are Shaping the Future of theNon-Alcoholic Steatohepatitis Biomarkers Industry?
The rise of technological innovation is a key shift noted in the non-alcoholic steatohepatitis biomarkers market. Leading businesses in this sector have been focusing on the development of state-of-the-art solutions to solidify their foothold. An example of this occurred in October 2022, when GENFIT, a late-stage biopharmaceutical firm from France, and LabCorp, a life sciences firm from the US, entered into an exclusive five-year licensing agreement for GENFIT’s NIS4 technology. This technology, aimed at identifying NASH-at-risk patients, is a unique multi-biomarker-based algorithm specially designed to detect patients with non-alcoholic steatohepatitis (NASH) with significant to advanced fibrosis (F > 2), also classified as at-risk NASH. As part of this pact, LabCorp will develop and bring to market a blood-based molecular diagnostic test leveraging NIS4 technology in the US and Canada, granting extensive access to healthcare practitioners.
Which Companies Are Leading the Charge in Expanding theNon-Alcoholic Steatohepatitis Biomarkers Market Growth?
Major companies operating in the non-alcoholic steatohepatitis biomarkers market include Genfit SA, Prometheus Laboratories Inc., Siemens Medical Solutions USA Inc., BioPredictive, Quest Diagnostics, AstraZeneca Plc., Laboratory Corporation of America Holdings, Pfizer Inc., Bristol-Myers Squibb Company, NGM Biopharmaceuticals Inc., Gilead Sciences Inc., Perspectum Diagnostics Ltd., One Way Liver SL, Enterome SA, Echosens SA, Cisbio Bioassays SAS, Celerion Inc., Boehringer Ingelheim GmbH Inc., Exalenz Bioscience Ltd., Novartis AG, Novo Nordisk A/S, Allergan PLC., Glympse Bio, HistoIndex Pte Ltd, Cirius Therapeutics, Intercept Pharmaceuticals, Viking Therapeutics, Madrigal Pharmaceuticals, Galmed Pharmaceuticals, Immuron Ltd, Metacrine
Order Your Report Now For A Swift Delivery:
How is the Global Non-Alcoholic Steatohepatitis Biomarkers Market Segemented?
The non-alcoholic steatohepatitis biomarkers market covered in this report is segmented –
1) By Type: Hepatic Fibrosis Biomarkers, Serum Biomarkers, Oxidative Stress Biomarkers, Apoptosis Biomarkers, Other Types
2) By Disease: Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity
3) By End Use: Research Institutes And Academics, Diagnostic Centers, Pharmaceutical Companies And Pharmaceutical Companies And Contract Research Organizations (CROs), Hospitals And Clinics, Other End-Uses
Subsegments:
1) By Hepatic Fibrosis Biomarkers: Hyaluronic Acid, Procollagen III N-terminal Propeptide (PIIINP), Fibrosis-4 (FIB-4) Index
2) By Serum Biomarkers: Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Adiponectin
3) By Oxidative Stress Biomarkers: Malondialdehyde (MDA), 8-Isoprostane, Advanced Oxidation Protein Products (AOPP)
4) By Apoptosis Biomarkers: Caspase-3, Cytochrome c, Liver Inhibitory Protein (LIP)
5) By Other Types: Metabolomic Biomarkers, Genetic Biomarkers, Inflammatory Biomarkers
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=9002&type=smp
Which Geographics are Influencing the Growth of the Non-Alcoholic Steatohepatitis Biomarkers Market?
North America was the largest region in the non-alcoholic steatohepatitis biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-alcoholic steatohepatitis biomarkers market during the forecast period. The regions covered in the non-alcoholic steatohepatitis biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Gobal Non-Alcoholic Steatohepatitis Biomarkers Maret 2025, By The Business Research Company:
Alcoholic – Beverages Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/alcoholic-beverages-global-market-report
Food And Beverages E-Commerce Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/food-and-beverages-ecommerce-global-market-report
Prosthetic Heart Valve Devices And Equipment Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
